1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Medical Affairs Reputations (US): Rheumatoid Arthritis

Medical Affairs Reputations (US): Rheumatoid Arthritis

  • November 2015
  • ID: 3607561
  • Format: PDF
  • By Firstword Pharma


Is your rheumatoid arthritis Medical Affairs team leading the pack or following on behind?

How are Medical Affairs teams from challenger brands shaping up when compared with those from well-established products in the rheumatoid arthritis category? How close is the pack? Or are there brands at the top and bottom ends set apart from everyone else on how well (or badly) they are regarded by physicians?
See where your Medical Affairs team comes in the latest ranking, together with insights into what services matter to physicians and where they would like further improvements. 
Don't forget, if you also buy the EU5 version  you'll get a free comparison report, saving you time understanding and analysing the differences uncovered between these crucial markets.

Brands covered

AbbVie'Humira (adalimumab)
Amgen'Enbrel (etanercept)
Bristol-Myers Squibb'Orencia (abatacept)
Janssen Biotech'Remicade (infliximab)?Simponi (golimumab)
Pfizer'Xeljanz (tofacitinib)
Roche'Actemra (tocilizumab)?Rituxan (rituximab)
UCB'Cimzia (certolizumab pegol)

Top Takeaways

One team stands out from the rest: One brand forges ahead on overall quality of interactions, but still has one key area to focus on for improvement
Report reveals the services that really matter: Physicians rank the services that they value the most so you can understand essential requirements
Core needs generally met: The key issues where physicians rely on Medical Affairs teams for help are awarded positive scores, even for the lower-ranking teams
Still room for improvement: Need-gap analysis reveals that in areas of secondary importance, physicians are still seeking more help from the Medical Affairs teams
Important needs of US and EU5 physicians vary: Differences are revealed in which services matter most to physicians. Get the comparison report free when you buy both the US and EU report.
Some information needs unfulfilled: See where you need to improve so that physicians are able to make informed decisions when assessing competing treatments

Key issues explored

How physicians rate your rheumatoid arthritis Medical Affairs team
Interaction quality, performance and satisfaction measured and compared both overall and on a drug-by-drug basis
How well physicians remember their interactions with your rheumatoid arthritis Medical Affairs team
Where physicians see information as lacking for your brand so you know where you need to improve. See where there are outstanding information needs for your brand that will assist physicians when they are making decisions about competing treatments
How often physicians like to be contacted and the way they prefer to conduct their interactions with Medical Affairs teams


100 rheumatologists across US participated in this study
Data was collected via a 15-minute internet-based questionnaire

Participants screened to ensure they:

See at least 5 patients for rheumatoid arthritis in a typical month
Have been in active practice between 3-35 years
Devote at least 50% of time to direct patient care
Have had an interaction with a Medical Affairs professional in the past 6 months for at least one of the listed products

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Chronic Urticaria Or Hives - Pipeline Review, H2 2019

Chronic Urticaria Or Hives - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Chronic Urticaria Or Hives - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Chronic Urticaria Or Hives - Pipeline Review, H2 2019, provides an overview of ...

Interleukin 1 - Pipeline Review, H1 2020

Interleukin 1 - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

Interleukin 1 - Pipeline Review, H1 2020SummaryInterleukin 1 (IL1) pipeline Target constitutes close to 24 molecules. Out of which approximately 23 molecules are developed by companies and remaining by ...

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020" provides ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on